1-3 of 3
Robert Vander Broek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma

Suresh Mohan, Robert Vander Broek, Sujay Shah, Danielle F. Eytan, Matthew L. Pierce, Sophie G. Carlson, Jamie F. Coupar, Jialing Zhang, Hui Cheng, Zhong Chen, Carter Van Waes
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17): 3946–3956.
https://doi.org/10.1158/1078-0432.CCR-14-3377
Published: 31 August 2015
View article titled, MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma
Open the PDF for MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer

Amanda Herzog, Yansong Bian, Robert Vander Broek, Bradford Hall, Jamie Coupar, Hui Cheng, Anastasia L. Sowers, John D. Cook, James B. Mitchell, Zhong Chen, Ashok B. Kulkarni, Carter Van Waes
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 3808–3819.
https://doi.org/10.1158/1078-0432.CCR-12-2716
Published: 15 July 2013
View article titled, PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer
Open the PDF for PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Inactivation or Loss of TTP Promotes Invasion in Head and Neck Cancer via Transcript Stabilization and Secretion of MMP9, MMP2, and IL-6

Elizabeth A. Van Tubergen, Rajat Banerjee, Min Liu, Robert Vander Broek, Emily Light, Shiuhyang Kuo, Stephen E. Feinberg, Amanda L. Willis, Gregory Wolf, Thomas Carey, Carol Bradford, Mark Prince, Francis P. Worden, Keith L. Kirkwood, Nisha J. D'Silva
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (5): 1169–1179.
https://doi.org/10.1158/1078-0432.CCR-12-2927
Published: 03 March 2013
View article titled, Inactivation or Loss of TTP Promotes Invasion in Head and Neck Cancer via Transcript Stabilization and Secretion of MMP9, MMP2, and IL-6
Open the PDF for Inactivation or Loss of TTP Promotes Invasion in Head and Neck Cancer via Transcript Stabilization and Secretion of MMP9, MMP2, and IL-6 in another window
Includes: Supplementary data